Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Too much risk
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GoldenDilemmaon Mar 13, 2017 10:49am
158 Views
Post# 25970828

RE:RE:RE:RE:RE:RE:RE:RE:Too much risk

RE:RE:RE:RE:RE:RE:RE:RE:Too much risk

And has been completely insane for more than just today if they have remained long and bought more through 2016/2017. 

The company will not be in an upward trajectory for a long time. Averaging down on a losing position in this circumstance is an absolute waste of money and takes on way more risk than is necessary (i.e.: keep your cash liquid, or buy something more attractive, or, short ARLZ on a spike). 

anyone buying completely misses the point of WHY ARLZ is down and has been down since Sept 2015. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities